The highly infectious variant of COVID-19 discovered in Kent, which swept across the UK last year before spreading worldwide, is between 30 and 100 per cent more deadly than previous strains, new analysis has shown.
Osteosarcoma is a painful and aggressive bone tumour in dogs that is known to be more common in certain breeds than others. New research has now confirmed that larger breeds, such as Rottweiler, Great Dane and Rhodesian Ridgeback, have a greater risk of osteosarcoma than smaller breeds, as well as showing that breeds with shorter skulls and legs have lower osteosarcoma risk. The findings could inform future breed health reforms as well as studies into the way tumours develop from normal bone.
Graduates of the University of Bristol are among the highest paid in the country three years after graduating, according to data released by the Department of Education.
There is an important absence of evidence regarding the effectiveness of a potentially cost-efficient intervention to prevent indoor transmission of respiratory infections, including COVID-19, warns a study by researchers at the University of Bristol.
Young people living in the Bristol area are already helping University of Bristol researchers to understand how children’s immune systems respond to COVID-19, but even more children are needed to take part, especially those from ethnic minorities.
Cleft lip and/or palate are common birth defects and affect around 15 in every 10,000 births in Europe. New research by the University of Bristol from the largest study of cleft lip and/or palate in the world, the Cleft Collective, has found epigenetics could help diagnose different types of cleft.
Volunteers from the Bristol area are being asked to sign up to the latest COVID-19 vaccine study to be rolled out across the UK.
Around 700 child deaths that occur in England each year might be avoided by reducing deprivation, finds a new NHS England-funded report published today [13 May]. The University of Bristol National Child Mortality Database (NCMD)-led analysis identified a clear association between the risk of death and level of deprivation for children in England, for all categories of death except cancer.
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India — one of the world’s most ethnically diverse countries.
The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘One Health’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security.
